The latest publications:

Interview with Aislinn Dunne, April 2022 in Red Sea Research Center KAUST magazine:

https://rsrc.kaust.edu.sa/news/detail/2022/04/21/student-focus-aislinn-dunne

Human Antibody Repertoires eBook, March 2022 in informaconnect:
https://informaconnect.com/ebook-human-antibody-repertoires/

The Long term impacts of COVID-19 on Clinical Trials, September 2021 in informaconnect:

https://informaconnect.com/future-clinical-trials-ebook-series/

Demonstrating sufficient clinical evidence under EU MDR eBook, September 2021 in informaconnect:

https://informaconnect.com/implementation-eu-mdr-medtech-series-ebook/

Interview with Silvia Vimercati at the Red Sea Research Center KAUST magazine, September 2021 in Issuu:

https://issuu.com/red_sea_research_center/docs/newsletter_i10_winter-spring_2021

Answers to your medical device technical files questions, September 2021 in Medical News Regulatory Insight:

https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-regulatory-i...

Personalised medicine: neoantigen cancer vaccines, May 2021 in informaconnect:

https://informaconnect.com/personalized-medicine-neoantigen-cancer-vaccines-t-cell-therapy/

Interview spotlight, April 2021, in Kolabtree:

https://www.kolabtree.com/blog/spotlight-interview-with-kolabtree-featured-freelance-scientific-writ...


Clinical Evaluation Report: 5 Tips to Improve Your CER for MDR Compliance, March 2021 in Infomed News

https://infomeddnews.com/cer-clinical-evaluation-writing-tips/


Oligonucleotide and Peptide Therapeutics TIDES Europe 2020 post-conference report, December 2020 in informaconnect:

https://informaconnect.com/tides-europe-2020-report/


Oligonucleotide and Peptide Therapeutics TIDES US 2020 post-conference report, November 2020 in informaconnect:

https://informaconnect.com/post-event-report-tides-oligonucleotide-and-peptide-therapeutics/?utm_sou...

EU MDR Approval: Performing the Literature Search, October 2020 in MedTech Intelligence

https://www.medtechintelligence.com/column/eu-mdr-approval-performing-the-literature-search/

When to outsource manufacturing? Advice for cell and gene therapy developers, September 2020 in informaconnect:

https://informaconnect.com/outsource-manufacturing-cell-gene-therapies/


Cortex Couture, September 2020 in Seisma Magazine:
https://seismamag.com

Upon the Stage, September 2020 in Seisma Magazine:
https://seismamag.com


Novel analytical strategies and tools for cell and gene therapies, September 2020 in informaconnect:

https://informaconnect.com/novel-analytical-cell-gene-therapies/


Oligonucleotides and peptides_ the regulatory challenges, July 2020  in informaconnect:
https://informaconnect.com/oligonucleotides-peptides-regulatory-challenges/


Diversity in the Life Sciences Workplace,
June 2020 in informaconnect:
https://informaconnect.com/diversity-life-sciences-corporate-culture-innovation/


Medical Device Literature Review - expert tips,
May 2020 in Kolabtree:

https://www.kolabtree.com/blog/literature-reviews-for-medical-devices-6-expert-tips/


Clinical Trial Patient Engagement - How technology is offering new approaches,
April 2020 in informaconnect:

https://informaconnect.com/clinical-trial-patient-engagement-technology-approaches-whitepaper/


Manufacturing oligonucleotides: addressing safety and delivery challenges, March 2020 in informaconnect:
https://informaconnect.com/manufacturing-oligonucleotides-safety-delivery-challenges/


Manufacturing Incident Reports (MIR) under the EU MDR, February 2020 in informaconnect:
https://informaconnect.com/manufacturing-incident-reports-eu-mdr-whitepaper/

Preparing you organisation for MDSAP: Australia, Canada, Japan and Brasil, February 2020 in informaconnect:
https://informaconnect.com/preparing-mdsap-australia-canada-japan-brazil-whitepaper/

Article 117: preparing Drug Device Combination product manufacturers for the EU MDR, February 2020 in informaconnect:
https://informaconnect.com/eu-mdr-article-117-drug-device-combination-products/

Next generation protein drug challenges and and the latest technologies to overcome them, February 2020 in informaconnect:

https://informaconnect.com/protein-drug-challenges-technologies-whitepaper/

EU MDR, new expectations for clinical evaluations and investigations, February 2020 in informaconnect:

https://informaconnect.com/eu-mdr-expectations-whitepaper/

EU MDR: assessing the impact on biocompatibility testing, February 2020 in informaconnect:

https://informaconnect.com/medical-device-regulation-biocompatibility-testing/

Insourcing vs Outsourcing in cell and gene therapy manufacturing, January 2020 in informaconnect:

https://informaconnect.com/insourcing-vs-outsourcing-cell-gene-therapy-manufacturing/

Regulatory challenges and strategies for oligonucleotide, peptide and mRNA therapeutics, January 2020 in informaconnect:

https://informaconnect.com/regulatory-challenges-strategies-oligonucleotide-peptide-mrna/


Novel technologies and approaches for optimising antibody discovery, December 2019, in informaconnect:

https://informaconnect.com/novel-technologies-and-approaches-for-optimizing-antibody-discovery-white...

Metabolomics, a go-to approach in Systems Biology, November 2019, in Technology Networks:
https://www.technologynetworks.com/proteomics/articles/metabolomics-a-go-to-approach-in-systems-biol...

3 Case Studies for implementing wearables in clinical trials, October 2019, in informaconnect:

https://informaconnect.com/wearables-clinical-trials-case-studies/

Clogged Synapses, better call the mailman (or have a shut-eye), November 2019, in Countlesssheep:

https://www.countlesssheep.com/sleep/clogged-synapses-better-call-the-mailman-or-have-a-shut-eye/


Bispecific antibody: ongoing clinical trials, September 2019, in informaconnect:

https://knect365.com/next-generation-therapeutics/article/e0a2599e-9b0d-461c-af7f-1a5935d6b57e/bispe...

https://informaconnect.com/the-emergence-and-benefits-of-bispecific-antibodies/



The emergence and benefits of bispecific antibodies, August 2019 in informaconnect:

https://informaconnect.com/the-emergence-and-benefits-of-bispecific-antibodies/


Major Milestones in Therapeutic Antibody Engineering, August 2019, in Technology Networks:

https://www.technologynetworks.com/biopharma/lists/major-milestones-in-therapeutic-antibody-engineer...


Balance, or "from what are you going to die of, today?", August 2019, in Countlesssheep:

https://www.countlesssheep.com/cool/intriguing/balance-its-all-about-balance/


CMC approaches to accelerate peptide, oligonucleotides, and mRNA therapeutics development, July 2019, in informaconnect:

https://knect365.com/next-generation-therapeutics/article/761c1a11-cd3b-4be8-8848-56ed3a828c3a/cmc-p...


Habenula, the master of the brain, June 2019, in Countlesssheep

https://www.countlesssheep.com/cool/habenula-the-master-of-the-brain/

Bispecific antibody engineering and therapeutics, May 2019, in informaconnect:

https://knect365.com/article/pdfs/dd270bd3-fcbd-498b-8cee-cc552f30208b_BispecificAntibodiesWhitepape...


Designing Novel Protein Therapeutics & Identifying Appropriate Targets, May 2019, in informaconnect:
https://informaconnect.com/designing-novel-protein-therapeutics-identifying-targets-whitepaper/


Underwater banquet, May 2019, in Countlesssheep:
https://www.countlesssheep.com/cool/underwater-banquet/


Using Wearables in Clinical Trials, April 2019, in informaconnect: 

https://informaconnect.com/wearables-clinical-trials-beyond-hype-whitepaper/


Alcohol or Melatonin, September 2018, in Countlesssheep:

https://www.countlesssheep.com/cool/alcohol-or-melatonin/